Results 11 to 20 of about 2,934,807 (337)

Heart Neoplasms in Children: Retrospective Analysis

open access: yesArquivos Brasileiros de Cardiologia, 2013
The advancement of noninvasive imaging methods has resulted in the increase in diagnosis of heart neoplasms. However, the literature has few studies involving primary cardiac neoplasms in children.To retrospectively review cases of primary heart neoplasms in children, considering the initial clinical manifestations, diagnostic tests used, surgical ...
Juliano Gomes, Penha   +9 more
openaire   +3 more sources

Combination of cardiac and carotid glomus tumour: a rare case report [PDF]

open access: yesFolia Medica, 2022
The most common tumour of the heart is myxoma but paraganglioma (also called glomus tumour in extracardiac sites) in the cardiac position is the rarest of them.
Feridoun Sabzi   +4 more
doaj   +3 more sources

Cardiac Myxoma among Patients Undergoing Cardiac Surgery in a Tertiary Care Center: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2022
Introduction: Heart neoplasms are rare tumors. Myxoma is the commonest primary benign tumor of the heart presenting with features of obstruction, arrhythmia, and embolism. Surgical excision of the tumor is the gold standard of treatment.
Prabhat Khakural   +3 more
doaj   +3 more sources

In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2023
Background Myeloproliferative neoplasms (MPNs) are chronic leukemias associated with increased risk of cardiovascular (CV) events. Prior studies suggest patients with MPN are at increased risk of HF. Additionally, pre-clinical murine models harboring the
O. Leiva   +4 more
semanticscholar   +1 more source

The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

open access: yesEuropean Heart Journal, 2021
Inflammation contributes centrally to cardiovascular diseases, and anti-inflammatory treatments can reduce cardiovascular events. The JAK-STAT pathway is an emerging target in inflammation, mainly in rheumatoid arthritis (RA) and chronic ...
C. Baldini   +4 more
semanticscholar   +1 more source

Clinical features and surgical treatment of right atrial tumors: a retrospective analysis of 64 cases

open access: yesDi-san junyi daxue xuebao, 2021
Objective To investigate the clinical characteristics of right atrial tumors and to analyze the experience and efficacy of surgical treatment. Methods The clinical data of 64 patients (37 females and 27 males, at a mean age of 47.0±16.4 years) with right
PAN Wencheng   +3 more
doaj   +1 more source

Cardiovascular Disease in Myeloproliferative Neoplasms

open access: yesJACC CardioOncology, 2022
Myeloproliferative neoplasms are associated with increased risk for thrombotic complications. These conditions most commonly involve somatic mutations in genes that lead to constitutive activation of the Janus-associated kinase signaling pathway (eg ...
O. Leiva, G. Hobbs, K. Ravid, P. Libby
semanticscholar   +1 more source

Benign tumors of the heart: Myxoma of the right atrium - a case report [PDF]

open access: yesVojnosanitetski Pregled, 2018
Introduction. Myxoma is the most common primary benign heart tumor. The most frequent location is the left atrium, the chamber of the heart that receives oxygen- rich blood from the lungs.
Hinić Saša   +10 more
doaj   +1 more source

Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot

open access: yesWorld Journal of Gastrointestinal Surgery, 2021
Our understanding about the epidemiological aspects, pathogenesis, molecular diagnosis, and targeted therapies of neuroendocrine neoplasms (NENs) have drastically advanced in the past decade.
C. Fernandez   +5 more
semanticscholar   +1 more source

Canagliflozin retards age-related lesions in heart, kidney, liver, and adrenal gland in genetically heterogenous male mice

open access: yesGeroScience, 2022
Canagliflozin (Cana), a clinically important anti-diabetes drug, leads to a 14% increase in median lifespan and a 9% increase in the 90th percentile age when given to genetically heterogeneous male mice from 7 months of age, but does not increase ...
J. Snyder   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy